Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses

The document discusses the role of Demodex mites, particularly Demodex folliculorum and Demodex brevis, in eye and skin disorders such as blepharitis and facial dermatoses. These mites are prevalent on human skin, especially in older individuals, and are linked to 60%-70% of dry eye cases due to their impact on the eyelids and meibomian glands. They can exacerbate inflammation by carrying bacteria and suppressing the host's immune response, contributing to conditions like rosacea. Diagnosis involves microscopic analysis, and treatment focuses on reducing mite populations through hygiene practices and medications like tetracycline, tea tree oil, and the FDA-approved XDEMVY™. Despite various treatments, no single method fully eradicates Demodex, indicating the chronic nature of the condition and the need for individualized treatment approaches. The document also notes that Demodex is considered a result rather than a cause of alopecia.